Top Markets
Coin of the day
Ascendis Health Limited Ascendis Health Limited

Ascendis Health Limited

ASC
Rank in Stocks #39751
Ascendis Health Limited is a health and wellness enterprise that manufactures... Ascendis Health Limited is a health and wellness enterprise that manufactures and distributes healthcare products across South Africa, Cyprus, Spain, Hungary, Romania, and other international markets. The company's operations are divided into three key segments: Consumer Health, Pharma, and Medical. Within its Consumer Health portfolio, it offers a variety of body and skin care items, alongside numerous supplements such as natural, multi-vitamin, mineral, micronutrient, and nutraceutical options, as well as homeopathic and herbal remedies, marketed under brands like Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce. The Medical segment provides essential medical devices, diagnostic laboratory equipment, and related consumables for diverse settings, including operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, and scientific research institutes. Concurrently, the Pharma division offers a wide array of generic pharmaceutical products, encompassing antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives, and treatments targeting the nervous and cardiovascular systems, dermatological issues, and antimalarial conditions, among other therapeutic solutions. These medical and pharmaceutical products are distributed under brands such as Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group. Ascendis Health also exports its products and serves a broad customer base including pharmacies, retailers, beauticians, and doctors. The company was founded in 2008 and is headquartered in Johannesburg, South Africa.
Share Price
$0.05742053
Last synced: 2025-11-28
Market Cap
$359.48K
Change (1 day)
7.05%
Change (1 year)
21.86%
Country
ZA
Trade Ascendis Health Limited (ASC)

Category

P/S ratio for Ascendis Health Limited (ASC)
P/S ratio as of 2026 TTM: 0
According to Ascendis Health Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Ascendis Health Limited from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors